Clinical Trial Update: Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the pharmacokinetics and safety of a combination inhaler containing fluticasone propionate and albuterol sulfate in children aged 4 to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) (fluticasone propionate multidose dry powder inhaler)
• Fluticasone Propionate and Albuterol Sulfate Combination Inhaler

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 1 | Status: COMPLETED